Update on the evidence of statin treatment to reduce plaque vulnerability

Drug Metab Lett. 2012 Sep 1;6(3):151-6. doi: 10.2174/1872312811206030001.

Abstract

Ischemic stroke represents one of the major causes of mortality and disability in the adult population in both developed and developing nations. Considering these epidemiological issues, the improvement of preventive therapeutic strategies has been recently targeted as a pivotal research field for scientific community. On the basis of the results from several large clinical studies and met analyses, some Task forces of researchers from recognized Scientific Societies have recently produced some consensus Guide lines, recommending the use of statins as a key pharmacologic approach in stroke prevention. In the present narrative review, we will update evidence on safety and efficacy of statins to prevent ischemic cerebral stroke.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Animals
  • Atherosclerosis / complications
  • Atherosclerosis / drug therapy
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Plaque, Atherosclerotic / complications
  • Plaque, Atherosclerotic / drug therapy*
  • Practice Guidelines as Topic
  • Stroke / etiology
  • Stroke / prevention & control*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors